Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01DIM
|
|||
| Drug Name |
CLL442
|
|||
| Indication | Cutaneous squamous cell carcinoma [ICD-11: 2C30] | Phase 1/2 | [1] | |
| Squamous cell carcinoma [ICD-11: 2B60-2D01; ICD-10: C44; ICD-9: 199] | Phase 1/2 | [2] | ||
| Company |
Novartis OncologyEast Hanover, NJ
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.